US › Healthcare

Utah Medical Products Inc (UTMD)

US · Healthcare · Medical Instruments & Supplies

$72.30-0.62%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$8.5M

Revenue YoY

-14.3%

Net profit

$2.7M

Profit YoY

-11.9%

EPS

$0.84

Net margin

31.5%

Key statistics

Market cap

$231.6M

P/E

22.2

Forward P/E

13.0

P/B

1.84

Book value

$37.80

EPS (TTM)

$3.28

Dividend yield

0.87%

52-week high

$75.75

52-week low

$52.87

50-day MA

$68.25

200-day MA

$63.19

Beta

0.36

Shareholding

Insiders

7.18%

Institutions

75.46%

Largest institutional holders

Fund	Stake
Brandes Investment Partners & Co	14.11%
Dimensional Fund Advisors, Inc.	6.22%
BlackRock Inc	5.89%
Renaissance Technologies Corp	5.78%
Vanguard Capital Management, LLC	4.35%
Geode Capital Management, LLC	3.77%
Minerva Advisors LLC	2.94%
Hotchkis & Wiley Capital Management LLC	2.80%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Utah Medical Products Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.